LIDAK PHARMACEUTICALS
4, 1998-09-10
PHARMACEUTICAL PREPARATIONS
Previous: NEW GERMANY FUND INC, N-23C-1, 1998-09-10
Next: CISCO SYSTEMS INC, 424B3, 1998-09-10




                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 4

           STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

     Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
        Section 17(a) of the Public Utilitiy Holding Company Act of 1935
             or Section 30(f) of the Investment Company Act of 1940

1.   Name and Address of Reporting Person

     Katz               David                H.
     (Last)            (First)              (Middle)

     1775 La Jolla Rancho Road    
     (Street)

     La Jolla          California       92037
     (City)            (State)          (Zip)

2.   Issuer Name and Ticker or Trading Symbol:  Lidak Pharmaceuticals (LDAKA)

3.   IRS or Social Security Number of Reporting Person (Voluntary)

4.   Statement for Month/Year:  August 1998

5.   If Amendment, Date of Original (Month/Day/Year)

6.   Relationship of Reporting Person to Issuer  (Check all applicable)

     /x /  Director                              /  /  10% Owner
     /  /  Officer (give title below)            /  /  Other (Specify below)
           President

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficiallly 
          Owned

                       2. Transaction   3. Transaction   4. Securities Acquired
                       Date (Month/     Code (Instr. 8)  (A) or Disposed (D)
1. Title of Security   Day/Year)        Code         V   (Instr. 3, 4 and 5)
   (Instr. 3)                                            Amount  (A) or   Price
                                                                 (D)

Class A Common Stock     08/27/98        J*              65,000   D       *

                       5. Amount of     6. Ownership     7. Nature of Indirect
                       Securities       Form: Direct     Beneficial Ownership
                       Beneficially     (D) or Indirect  (Instr. 4)
                       Owned at End     (I) (Instr. 4)
                       of Month 
                       (Instr. 3 and 4)

     Class A Common Stock 929,103        D
     

                      

Reminder:  Report on a separate line for each class of  securities  beneficially
owned directly or indirectly

If the form is filed by more than one reporting person, see Instruction 5(b)(v).
<PAGE>

Table II: Derivative Security  Beneficially Owned (e.g., puts, calls,  warrants,
options, convertible securities)

                                            
                         2. Conversions     3. Transaction  4. Transaction Code
1. Title of Derivative   or Exercise Price  Date (Month/    (Instr. 8)
Security (Instr. 4)      of Derivative      Day/Year)
                         Security           


                         5. Number of         6. Date Exercisable and 
                         Derivative Securities Expiration Date (Month/Day/Year)
                         Acquired (A) or      
                         Disposed of (D)      Date Exercisable  Expiration Date
                         (Instr. 3, 4 and 5)
  
                         Amount  (A) or (D)
                          
                          
                                              
                         7. Title and Amount of Underlying Securities  
                         (Instr. 3 and 4)            

                         Title                  Amount or Number
                                                of Shares

                         

                         8. Price of         9. Number of Derivative
                         Derivative Security Securities Beneficially
                         (Instr. 5)          Owned at End of Month
                                             (Instr. 4)
                                              
                                        Class A Common Stock Options: 1,913,903
                                        Class B Common Stock Options:   385,000
                                        Class D Warrants:               386,190

                         10. Ownership Form       11. Nature of Indirect
                         of Derivative Security:  Beneficial Ownership
                         Direct (D) or Indirect   (Instr. 4)
                         (I) (Instr. 4) 

                         

Explanation of Responses: 

*Shares  transferred  to an  unrelated  party in  connection  with a  settlement
agreement-related  contract.  See  Schedule  13D filed  with the  Commission  on
September  3, 1998.  The market value of the shares on August 27, 1998 was $1.03
per share.

** Intentional  misstatements or omissions of facts constitute  Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).



                                             /s/ David H. Katz
                                            _____________________________
                                            Signature of Reporting Person


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission